These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors]. Kitaichi Y Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979 [No Abstract] [Full Text] [Related]
4. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703 [TBL] [Abstract][Full Text] [Related]
5. Some aspects of the mechanism of action of various stimulant amphetamine analogues. Scheel-Krüger J Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652 [No Abstract] [Full Text] [Related]
6. Pharmacology of clovoxamine, a new non-tricyclic antidepressant. Claassen V; Boschman TA; Dhasmana KM; Hillen FC; Vaatstra WJ; Zwagemakers JM Arzneimittelforschung; 1978; 28(10):1756-66. PubMed ID: 582680 [No Abstract] [Full Text] [Related]
7. [Data on the biochemical mechanism of action of antidepressive psychopharmacologic agents]. Baconcini C; Muzio M Sist Nerv; 1971; 23(7):25-35. PubMed ID: 4360412 [No Abstract] [Full Text] [Related]
8. The effect of psychotropic drugs on the metabolism of cerebral monoamines. Pletscher A Shinkei Kenkyu No Shimpo; 1966 Jul; 10(2):303-4. PubMed ID: 6010309 [No Abstract] [Full Text] [Related]
9. Studies of bupropion's mechanism of antidepressant activity. Ferris RM; Cooper BR; Maxwell RA J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468 [TBL] [Abstract][Full Text] [Related]
10. [Adrenergic mechanisms of antidepressant action]. Mashkovskiĭ MD Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):750-9. PubMed ID: 4916171 [No Abstract] [Full Text] [Related]
11. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models. Baizman ER; Ezrin AM; Ferrari RA; Luttinger D J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867 [TBL] [Abstract][Full Text] [Related]
12. [New studies on the use of antidepressants]. Deniker P; Loo H; Zarifian E Ann Med Psychol (Paris); 1980 Jan; 138(1):103-13. PubMed ID: 6104461 [TBL] [Abstract][Full Text] [Related]
13. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. Fuller RW; Hemrick-Luecke SK; Snoddy HD J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356 [TBL] [Abstract][Full Text] [Related]
17. Mianserin, an antidepressant with a unique neuropharmacological profile. Leonard BE Acta Psychiatr Belg; 1978; 78(5):770-80. PubMed ID: 35926 [No Abstract] [Full Text] [Related]
18. The contribution of drug research to investigating the nature of endogenous depression. Carlsson A Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):2-10. PubMed ID: 10584 [TBL] [Abstract][Full Text] [Related]
19. Current theories on the mode of action of antidepressant drugs. Carlsson A Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723 [No Abstract] [Full Text] [Related]
20. [Inhibition of noradrenaline deamination by antidepressants]. Moskvitina TA; Gankina EM; Val'dman AV Biull Eksp Biol Med; 1986 Jul; 102(7):44-6. PubMed ID: 3730591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]